 | Spero Therapeutics: The GlaxoSmithKline-Deal Changes Everything And Protects Shareholder Value
seekingalpha.com - October 3 at 8:34 AM |
 | Spero Therapeutics to Host Virtual R&D Event on Non-Tuberculous Mycobacterial Pulmonary Disease and the SPR720 Program
finance.yahoo.com - October 3 at 8:34 AM |
 | Aquilo Capital Management, Llc Sells 1,901,796 Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock
americanbankingnews.com - September 29 at 4:06 AM |
| HC Wainwright Lowers Spero Therapeutics (NASDAQ:SPRO) Price Target to $6.00
americanbankingnews.com - September 28 at 2:12 AM |
| Spero Therapeutics (NASDAQ:SPRO) Price Target Lowered to $6.00 at HC Wainwright
americanbankingnews.com - September 26 at 7:36 AM |
| This Infection-Fighting Biotech Is Recovering Nicely
finance.yahoo.com - September 25 at 8:03 AM |
| Evercore ISI Upgrades Spero Therapeutics (NASDAQ:SPRO) to "Outperform"
americanbankingnews.com - September 25 at 3:48 AM |
| Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK
finance.yahoo.com - September 23 at 2:41 PM |
 | Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
benzinga.com - September 23 at 10:42 AM |
 | GSK eyes Spero's experimental urinary tract infection drug, takes stake
msn.com - September 22 at 12:36 PM |
 | GSK To Receive Licence From Spero To Develop, Commercialise Tebipenem Pivoxil HBr
markets.businessinsider.com - September 22 at 7:36 AM |
|
| GSK takes stake in Spero in deal for experimental UTI treatment
msn.com - September 22 at 7:36 AM |
| Spero stock soars 79% as GSK to pick stake under license deal for UTI antibiotic
seekingalpha.com - September 22 at 7:36 AM |
 | Spero Therapeutics Shares Take Flight Premarket on GSK Pact >SPRO
marketwatch.com - September 22 at 7:36 AM |
| GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr
finance.yahoo.com - September 22 at 2:35 AM |
| Spero Therapeutics Announces Appointment of Kamal Hamed, MD, MPH, MBA, as Chief Medical Officer
finance.yahoo.com - September 15 at 8:11 PM |
 | Spero Therapeutics Rises
nasdaq.com - September 7 at 5:48 PM |
| Spero Therapeutics to Present at Upcoming Investor Conference
finance.yahoo.com - September 7 at 12:48 PM |
| Spero (SPRO) Up Following Positive FDA Update for UTI Drug
finance.yahoo.com - September 7 at 12:48 PM |
| Analyzing Spero Therapeutics's Short Interest
msn.com - September 6 at 4:46 PM |
| Spero Therapeutics Shares Jump After Upbeat FDA Feedback For Tebipenem HBr Program
finance.yahoo.com - September 6 at 4:46 PM |
| Spero Therapeutics Discusses Resubmission Of NDA For Tebipenem HBr After Discussion With FDA
nasdaq.com - September 6 at 11:45 AM |
| Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration
finance.yahoo.com - September 6 at 11:45 AM |
| Can Spero Therapeutics (NASDAQ:SPRO) Afford To Invest In Growth?
finance.yahoo.com - September 5 at 10:25 AM |
| Spero Therapeutics, Inc. (SPRO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - August 25 at 11:50 AM |
| Spero Therapeutics, Inc. (SPRO) CEO Ankit Mahadevia on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 8:30 PM |
| Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business Update
nz.finance.yahoo.com - August 10 at 9:04 PM |
| Spero Therapeutics is about to announce earnings — here's what Wall Street expects
markets.businessinsider.com - August 10 at 11:03 AM |
| Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
finance.yahoo.com - August 9 at 11:50 AM |
| FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
benzinga.com - July 25 at 2:59 PM |
 | DEADLINE ALERT for SPRO, LMPX, MF, and YQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
apnews.com - July 25 at 2:59 PM |
|
| The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPRO, OM and MF
benzinga.com - July 25 at 2:59 PM |
| Pomerantz Law Firm Announces the Filing of a Class Action Against Spero Therapeutics, Inc. and Certain Officers - SPRO
morningstar.com - July 23 at 9:06 AM |
| The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CDNA, SPRO and TGTX
benzinga.com - July 22 at 1:00 PM |
| CLASS ACTION UPDATE for SPRO, WM and OM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
benzinga.com - July 21 at 11:02 AM |
| The Women Who Shaped Short-Term Rental History
finance.yahoo.com - July 6 at 4:07 AM |
 | Spero Therapeutics Plummets 15% on FDA's CRL for Tebipenem HBr New Drug Application
investing.com - June 27 at 5:55 PM |
| U.S. FDA declines to approve Spero's urinary tract infection drug
nasdaq.com - June 27 at 5:55 PM |
| FDA rejects Spero's application seeking approval of its urinary tract infection tablets
seekingalpha.com - June 27 at 5:55 PM |
| Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug Application
finance.yahoo.com - June 27 at 5:55 PM |
| UPDATE 1-U.S. FDA declines to approve Spero's urinary tract infection drug
finance.yahoo.com - June 27 at 5:55 PM |
| INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Spero Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
apnews.com - June 17 at 5:42 PM |
| Spero Therapeutics, Inc. Investor News: Robbins LLP is Investigating Spero Therapeutics, Inc. (SPRO) on Behalf of Shareholders
apnews.com - June 16 at 11:52 AM |
| Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)
apnews.com - June 10 at 6:31 PM |
| SPRO LAWSUIT ALERT: Levi & Korsinsky Notifies Spero Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
morningstar.com - June 10 at 9:19 AM |
| SPRO ALERT: The Klein Law Firm Announces a Lead...
benzinga.com - June 8 at 8:05 AM |
 | The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Spero Therapeutics, Inc. (SPRO) Investors
tmcnet.com - June 6 at 3:58 PM |
| CLASS ACTION UPDATE for AMZN, SPRO and IONQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
benzinga.com - June 3 at 3:23 PM |
| The Law Offices of Frank R. Cruz Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of Investors
apnews.com - June 3 at 3:31 AM |
| INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Spero Therapeutics, Inc. (SPRO) on Behalf of Investors
apnews.com - June 2 at 10:30 PM |
